Reproductive Health in Men and Women With Vasculitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

467 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-02-28

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vasculitis Pregnancy Registry

NCT02593565

Vasculitis Behcet's Disease CNS Vasculitis +12 more

RECRUITING

Journey of Patients With Vasculitis From First Symptom to Diagnosis

NCT03410290

Vasculitis Systemic Vasculitis Behcet's Disease +13 more

COMPLETED

Impact of Vasculitis on Employment and Income

NCT02476292

Vasculitis Systemic Vasculitis Behcet's Disease +10 more

COMPLETED

One-Time DNA Study for Vasculitis

NCT01241305

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) Giant Cell Arteritis Granulomatosis With Polyangiitis (Wegener's) +3 more

RECRUITING

Educational Needs of Patients With Systemic Vasculitis

NCT02190929

Behcet's Disease Churg-Strauss Syndrome Vasculitis, Central Nervous System +6 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients enrolled in the Vasculitis Clinical Research Consortium's Contact Registry were invited via email to participate in this study. The Contract Registry includes people who self-identify as having one of 6 vasculitities: Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosum, Takayasu's Arteritis, and Giant Cell Arteritis. People voluntarily enroll in this Registry with the understanding that they will receive information about clinical studies for which they might be eligible. The introductory email included basic information about the study and all of the required elements for informed consent in a brief format. By clicking the link to the reproductive health questionnaire, participants gave their consent to be included in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Giant Cell Arteritis Takayasu's Arteritis Polyarteritis Nodosa Wegener's Granulomatosis Microscopic Polyangiitis Churg-Strauss Syndrome Behcet's Disease Kawasaki Disease Henoch-schoenlein Purpura Vasculitis, Central Nervous System Drug-induced Necrotizing Vasculitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Enrolled in VCRC Contact Registry
* Patient reported diagnosis of Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosa, Takayasu's Arteritis, Giant Cell Arteritis, Behcet's Disease, Kawasaki Disease, Henoch-Schoenlein Purpura, CNS or Drug-induced Vasculitis
* 18 years of age or older
* English speaking